Keck Hospital of USC-Norris Healthcare (HC3), Investigational Drug Service (IDS) is a clinical research site located in Los Angeles, California, United States 90033.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Keck Hospital of USC-Norris Healthcare (HC3), Investigational Drug Service (IDS) has participated in 1 clinical trials.
Therapeutic areas: Breast Cancer.
Sponsors: Stemline Therapeutics, Inc..
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Keck Hospital of USC-Norris Healthcare (HC3), Investigational Drug Service (IDS) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Keck Hospital of USC-Norris Healthcare (HC3), Investigational Drug Service (IDS) has 1 clinical trials on record. Their work covers Breast Cancer.
Keck Hospital of USC-Norris Healthcare (HC3), Investigational Drug Service (IDS) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.